Whitehawk Therapeutics annual operating margin
2018
2020
2021
2022
2023
2024
2025
Whitehawk Therapeutics's operating margin was −1,601.12% for fiscal 2025.
View full Whitehawk Therapeutics company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −1,601.12% | −1341.50 pp |
| 2024 | 2024-12-31 | −259.62% | +35.74 pp |
| 2023 | 2023-12-31 | −295.36% | +116.58 pp |
| 2022 | 2022-12-31 | −411.94% | +382.47 pp |
| 2021 | 2021-12-31 | −794.41% | −776.20 pp |
| 2020 | 2020-12-31 | −18.21% | +37.26 pp |
| 2018 | 2018-12-31 | −55.47% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2025 | 2025-03-31 | −212.99% | +151.52 pp |
| Q4 2024 | 2024-12-31 | −261.76% | +18.26 pp |
| Q3 2024 | 2024-09-30 | −185.98% | +113.55 pp |
| Q2 2024 | 2024-06-30 | −252.21% | +62.93 pp |
| Q1 2024 | 2024-03-31 | −364.51% | −77.73 pp |
| Q4 2023 | 2023-12-31 | −280.02% | +15.96 pp |
| Q3 2023 | 2023-09-30 | −299.53% | +54.67 pp |
| Q2 2023 | 2023-06-30 | −315.14% | +219.05 pp |
| Q1 2023 | 2023-03-31 | −286.77% | +312.01 pp |
| Q4 2022 | 2022-12-31 | −295.98% | −181.11 pp |
| Q3 2022 | 2022-09-30 | −354.20% | +3051.63 pp |
| Q2 2022 | 2022-06-30 | −534.19% | +618.63 pp |
| Q1 2022 | 2022-03-31 | −598.79% | −660.49 pp |
| Q4 2021 | 2021-12-31 | −114.87% | −174.36 pp |
| Q1 2021 | 2021-03-31 | −3,405.83% | −2953.10 pp |
| Q3 2020 | 2020-09-30 | −1,152.81% | — |
| Q2 2020 | 2020-06-30 | 61.71% | — |
| Q3 2018 | 2018-09-30 | 59.49% | — |
| Q2 2018 | 2018-06-30 | −452.73% | — |
Over the last five reported fiscal years, Whitehawk Therapeutics's operating margin decreased from −18.21% to −1,601.12%, a change of −1582.91 percentage points. The latest reported quarter, Q1 2025, shows −212.99%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Whitehawk Therapeutics filings at SEC.gov ↗